Published August 2011 | Version v1
Journal article Metadata-only

Radiation therapy for T2 supraglottic cancer

Creators

  • 1. Kurume Univ., School of Medicine, Kurume, Fukuoka (Japan)

Description

We retrospectively analyzed 33 cases of T2 supraglottic cancer that had undergone radical radiotherapy in our hospital. We classified supraglottis into two subtypes, epilarynx and supraglottis excluding epilarynx. The 5-year local control rates of epilarynx cancer was 92%, and that of supraglottic cancer excluding epilarynx was 73%. The supraglottic cancer excluding epilarynx tend to resist radiotherapy. We have to decide treatment method carefully either conservative operation or radiotherapy for T2 supraglottic cancer excluding epilarynx. (author)

Additional details

Publishing Information

Journal Title
Rinsho Hoshasen
Journal Volume
56
Journal Issue
8
Journal Page Range
p. 983-988
ISSN
0009-9252

INIS

Country of Publication
Japan
Country of Input or Organization
Japan
INIS RN
43005219
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
CARCINOMAS; CHEMOTHERAPY; COMBINED THERAPY; FRACTIONATED IRRADIATION; LARYNGECTOMY; LARYNX; LYMPH NODES; PATHOLOGICAL CHANGES; PATIENTS; RADIATION DOSES; RADIOTHERAPY; SURVIVAL CURVES; TONGUE; X RADIATION
Descriptors DEC
BODY; DIGESTIVE SYSTEM; DISEASES; DOSES; ELECTROMAGNETIC RADIATION; IONIZING RADIATIONS; IRRADIATION; LYMPHATIC SYSTEM; MEDICINE; NEOPLASMS; NUCLEAR MEDICINE; ORAL CAVITY; ORGANS; RADIATIONS; RADIOLOGY; RESPIRATORY SYSTEM; SURGERY; THERAPY